CVKD – cadrenal therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cadrenal Therapeutics (CVKD) had its price target lowered by HC Wainwright from $32.00 to $13.00. They now have a "buy" rating on the stock.
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion [Yahoo! Finance]
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Form D Cadrenal Therapeutics,
Form 8-K Cadrenal Therapeutics, For: Mar 31
Form 424B5 Cadrenal Therapeutics,
Form 10-K Cadrenal Therapeutics, For: Dec 31
Form 8-K Cadrenal Therapeutics, For: Mar 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.